Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The oral and dermal LD50 were determined to be >2000 mg/kg bodyweight.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
> 2 000 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
LD50
Value:
> 2 000 mg/kg bw

Additional information

In an acute oral toxicity test, performed according to OECD guideline 401 and GLP principles, five male and five female Wistar rats received a single dose of 2000 mg/kg bw. No deaths and no signs of toxicity were observed. The oral LD50 of MDI/CHA/ODA was therefore found to be > 2000 mg/kg bodyweight.
In an acute dermal toxicity test, performed according to OECD guideline 402 and GLP principles, five male and five female Wistar rats received a single (occlusive for 24 hours) dose of 2000 mg/kg bw. No deaths and no signs of toxicity were observed. The dermal LD50 of MDI/CHA/ODA was therefore found to be > 2000 mg/kg bodyweight.

Justification for classification or non-classification

Based on the available study results, MDI/CHA/ODA does not have to be classified for acute oral and acute dermal toxicity according to Regulation (EC) No 1272/2008.